Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Attenuated Inflammatory Response in Laparoscopic Colon Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01419431
Recruitment Status : Completed
First Posted : August 18, 2011
Last Update Posted : December 16, 2011
Information provided by (Responsible Party):
Dag T Førland, Oslo University Hospital

Brief Summary:
Pro-inflammatory responses following laparoscopic surgery.

Condition or disease Intervention/treatment
Regulation of Inflammatory Response Procedure: Laparoscopic resection

Detailed Description:
Blood samples from 20 patient with colon cancer collected before and in 3 days following laparoscopic surgery. Analyzed for inflammatory cytokines and corresponding SOCS3 mRNA.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Increased SOCS 3 mRNA in Monocytes From Patients Subjected to Laparoscopic Colon Surgery
Study Start Date : January 2007
Actual Primary Completion Date : November 2011
Actual Study Completion Date : December 2011

Group/Cohort Intervention/treatment
Colon cancer patients
Laparoscopic resection
Procedure: Laparoscopic resection
Inflammatory response in laparoscopic surgery
Other Name: Colon cancer

Primary Outcome Measures :
  1. Inflammatory values for laparoscopic resection for colon cancer. [ Time Frame: 3 days ]
    Corresponding values of SOCS3 mRNA copared to inflammatory cytokines in patients with laparoscopic resection for colon cancer.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Colon cancer stage I-III

Inclusion Criteria:Colon cancer stage I-III -

Exclusion Criteria:Colon cancer stage IV


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01419431

Layout table for location information
Oslo University Hospital
Oslo, Norway, 0407
Sponsors and Collaborators
Oslo University Hospital
Layout table for investigator information
Principal Investigator: Dag T. Førland, MD OUS

Layout table for additonal information
Responsible Party: Dag T Førland, MD, Oslo University Hospital Identifier: NCT01419431    
Other Study ID Numbers: SOCS3 mRNA
SOCS-3-202008 ( Other Grant/Funding Number: OUS-SOCS3 )
First Posted: August 18, 2011    Key Record Dates
Last Update Posted: December 16, 2011
Last Verified: December 2011
Keywords provided by Dag T Førland, Oslo University Hospital:
Colon cancer